Heart Failure

The company is a medical devices company that has developed an innovative implantable apparatus for the treatment of heart failure. Heart failure is characterized by a gradual weakening of the heart that leads to a loss of contractile function, marked by decrease in delivery of oxygenated blood to the body...

Diagnostics, Urology

The company is a medical devices company that has developed a technological platform utilizing near infrared spectroscopy to develop non-invasive diagnostic instruments for urologic conditions. Near infrared spectroscopy uses a specific, characteristic light source (near infrared light wavelength) that can...

Drug Delivery, Cancer

The company is a medical device company that has developed a cutting edge catheter-based drug delivery technology that enables the delivery of drugs to highly specific sites in patients. The company’s technology enables the set-in positioning of catheters at the site of interest, and then infuses drugs...

Diagnostics

The company is a medical devices company that has developed advanced diagnostic technology for detection of bacterial infections and their antibiotic susceptibility. The company’s novel mechanism uses bacteria-specific viruses that serve as markers to identify specific bacteria in patient samples. The...

Making Reimbursement Work In a Post-Healthcare Reform World

The passage of healthcare reform in March brought a wave of reimbursement-related headaches to the life science industry. The pharmaceutical industry will have to dole out $80 billion in discounts over the next 10 years, while a 2.3% excise tax levied on medical device sales has created consternation among...

[OneMedForum] MacuCLEAR Sees Unmet Need for Vision-Loss Treatment

With the large Baby Boomer population reaching its senior years, the incidence of age-related vision loss in the U.S. is expected to increase. Specifically, experts are anticipating a rise in age-related macular degeneration (AMD), the leading cause of blindness for people over 60. AMD, which destroys a...

OneMedPlace Announces Panel Discussions and Workshops for “2010 New York OneMedForum”

OneMedPlace announced today that its “2010 New York OneMedForum” finance conference, which will be held next week — June 29-30, 2010, at New York’s historic Roosevelt Hotel — will include two panel discussions and eight workshops. In addition, 74 private and public companies...

The Value of Intellectual Property

As Big Pharma can testify, protecting your intellectual property is important. The patents on a number of big-name drugs, including Avandia, Lipitor, and Plavix are set to expire in the next couple of years. The original manufacturers will lose their exclusive rights to produce these drugs, paving the way...